| Secondary Central Nervous System Lymphoma studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT03964090Phase 2 · active not recruiting Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05351593Phase 1/Phase 2 · recruiting Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07082868Phase 1 · recruiting A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL) · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06922604Phase 1 · suspended Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131022Phase 1 · recruiting A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137494Phase 1 · recruiting A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL) · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011045recruiting Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256641Phase 1/Phase 2 · recruiting Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681195Phase 2 · recruiting Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07410520Phase 2 · recruiting PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL. · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03703167Phase 1 · completed Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL) · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05485753Phase 1/Phase 2 · active not recruiting A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL) · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04438044Phase 2 · unknown A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05398224Phase 2 · unknown R-MTX-zanbrutinib in Secondary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04457869Phase 2 · unknown A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL) · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Secondary Central Nervous System Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |